This opportunity is no longer accepting applications.
grant RFA-MH-25-190

Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)

This grant opportunity aims to develop tools or biomarkers that can predict how individual patients will respond to various existing depression treatments. It is a two-phase program. In the first phase, researchers will identify potential tools or biomarkers using data from past clinical trials, real-world data, or small pilot studies. The second phase involves conducting trials to validate th…

The purpose of this phased Notice of Funding Opportunity (NOFO) is to create a pipeline to accelerate the development and early validation of predictive tools and/or biomarkers to inform individual-level treatment selection among two or more existing therapeutics for depression. This phased inte…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Open for Submission: April 3, 2024
Opportunity Released: April 3, 2024
Submission Deadline: October 18, 2024
Application Window Closes: October 18, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.